Erratum for: Odwe et al., Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda

doi:10.9745/GHSP-D-19-00036

In the article “Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels” by George Odwe and colleagues, which appeared in the December 2018 issue (Volume 6, Number 4), in Table 4, the content for footnotes ‘b’ and ‘c’ were reversed. This has now been corrected.

Notes

Cite this article as: Erratum for: Odwe et al., Introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) injectable contraception at facility and community levels: pilot results from 4 districts of Uganda. Glob Health Sci Pract. 2019;7(1):147. https://doi.org/10.9745/GHSP-D-19-00036

Published: 2019 Mar 22.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-19-00036